BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Endo-Takahashi Y, Negishi Y. Microbubbles and Nanobubbles with Ultrasound for Systemic Gene Delivery. Pharmaceutics 2020;12:E964. [PMID: 33066531 DOI: 10.3390/pharmaceutics12100964] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu Y, Deng C, Xu J, Wang W, Chen Y, Qin X, Lv Q, Xie M. Enhanced Local Delivery of microRNA-145a-5P into Mouse Aorta via Ultrasound-Targeted Microbubble Destruction Inhibits Atherosclerotic Plaque Formation. Mol Pharm 2023;20:1086-95. [PMID: 36656656 DOI: 10.1021/acs.molpharmaceut.2c00799] [Reference Citation Analysis]
2 Fournier L, de La Taille T, Chauvierre C. Microbubbles for human diagnosis and therapy. Biomaterials 2023;294:122025. [PMID: 36716588 DOI: 10.1016/j.biomaterials.2023.122025] [Reference Citation Analysis]
3 Qin Y, Geng X, Sun Y, Zhao Y, Chai W, Wang X, Wang P. Ultrasound nanotheranostics: Toward precision medicine. J Control Release 2023;353:105-24. [PMID: 36400289 DOI: 10.1016/j.jconrel.2022.11.021] [Reference Citation Analysis]
4 Yano Y, Hamano N, Haruta K, Kobayashi T, Sato M, Kikkawa Y, Endo-Takahashi Y, Tada R, Suzuki R, Maruyama K, Nomizu M, Negishi Y. Development of an Antibody Delivery Method for Cancer Treatment by Combining Ultrasound with Therapeutic Antibody-Modified Nanobubbles Using Fc-Binding Polypeptide. Pharmaceutics 2022;15. [PMID: 36678759 DOI: 10.3390/pharmaceutics15010130] [Reference Citation Analysis]
5 Hansen HHWB, Cha H, Ouyang L, Zhang J, Jin B, Stratton H, Nguyen NT, An H. Nanobubble technologies: Applications in therapy from molecular to cellular level. Biotechnol Adv 2022;63:108091. [PMID: 36592661 DOI: 10.1016/j.biotechadv.2022.108091] [Reference Citation Analysis]
6 Capolla S, Argenziano M, Bozzer S, D’agaro T, Bittolo T, Leo L, Not T, Busato D, Bo M, Toffoli G, Cavalli R, Gattei V, Bomben R, Macor P. Targeted chitosan nanobubbles as a strategy to down-regulate microRNA-17 into B-cell lymphoma models.. [DOI: 10.21203/rs.3.rs-2277122/v1] [Reference Citation Analysis]
7 Guo X, Huang Z, Chen J, He K, Lin J, Zhang H, Zeng Y. Synergistic delivery of resveratrol and ultrasmall copper-based nanoparticles by aptamer-functionalized ultrasound nanobubbles for the treatment of nonalcoholic fatty liver disease. Front Physiol 2022;13:950141. [DOI: 10.3389/fphys.2022.950141] [Reference Citation Analysis]
8 Man VH, He X, Wang J. Stable Cavitation Interferes with Aβ16-22 Oligomerization. J Chem Inf Model 2022. [PMID: 35920625 DOI: 10.1021/acs.jcim.2c00764] [Reference Citation Analysis]
9 Zhang S, Li E, Liu Z, Shang H, Chen Y, Jing H. Nanoparticle-based Olaparib delivery enhances its effect, and improves drug sensitivity to cisplatin in triple negative breast cancer. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103731] [Reference Citation Analysis]
10 Kida H, Feril LB, Irie Y, Endo H, Itaka K, Tachibana K. Influence of Nanobubble Size Distribution on Ultrasound-Mediated Plasmid DNA and Messenger RNA Gene Delivery. Front Pharmacol 2022;13:855495. [PMID: 35721213 DOI: 10.3389/fphar.2022.855495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li CH, Chang YC, Hsiao M, Chan MH. Ultrasound and Nanomedicine for Cancer-Targeted Drug Delivery: Screening, Cellular Mechanisms and Therapeutic Opportunities. Pharmaceutics 2022;14:1282. [PMID: 35745854 DOI: 10.3390/pharmaceutics14061282] [Reference Citation Analysis]
12 Shinu P, Morsy MA, Nair AB, Mouslem AKA, Venugopala KN, Goyal M, Bansal M, Jacob S, Deb PK. Novel Therapies for the Treatment of Neuropathic Pain: Potential and Pitfalls. J Clin Med 2022;11:3002. [PMID: 35683390 DOI: 10.3390/jcm11113002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Song S, Lyle MJ, Noble-vranish ML, Min-tran DM, Harrang J, Xiao W, Unger EC, Miao CH. Ultrasound-mediated gene delivery of factor VIII plasmids for hemophilia A gene therapy in mice. Molecular Therapy - Nucleic Acids 2022;27:916-926. [DOI: 10.1016/j.omtn.2022.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Delaney LJ, Isguven S, Eisenbrey JR, Hickok NJ, Forsberg F. Making waves: how ultrasound-targeted drug delivery is changing pharmaceutical approaches. Mater Adv . [DOI: 10.1039/d1ma01197a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Miguel V, Lamas S. MicroRNA control of kidney disease. MicroRNA 2022. [DOI: 10.1016/b978-0-323-89774-7.00019-4] [Reference Citation Analysis]
16 de Freitas CF, Tessaro AL, Pellosi DS. Polymeric Nanoparticles for Theranostic Treatment of Cancer. Functional Biomaterials 2022. [DOI: 10.1007/978-981-16-7152-4_6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Li H, Zhang Y, Shu H, Lv W, Su C, Nie F. Highlights in ultrasound-targeted microbubble destruction-mediated gene/drug delivery strategy for treatment of malignancies. Int J Pharm 2021;:121412. [PMID: 34942327 DOI: 10.1016/j.ijpharm.2021.121412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Rowe SP, Pomper MG. Molecular imaging in oncology: Current impact and future directions. CA Cancer J Clin 2021. [PMID: 34902160 DOI: 10.3322/caac.21713] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
19 Walsh APG, Gordon HN, Peter K, Wang X. Ultrasonic particles: An approach for targeted gene delivery. Adv Drug Deliv Rev 2021;179:113998. [PMID: 34662671 DOI: 10.1016/j.addr.2021.113998] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
20 Athanassiadis AG, Ma Z, Moreno-Gomez N, Melde K, Choi E, Goyal R, Fischer P. Ultrasound-Responsive Systems as Components for Smart Materials. Chem Rev 2021. [PMID: 34767350 DOI: 10.1021/acs.chemrev.1c00622] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
21 Rousou C, Schuurmans CCL, Urtti A, Mastrobattista E, Storm G, Moonen C, Kaarniranta K, Deckers R. Ultrasound and Microbubbles for the Treatment of Ocular Diseases: From Preclinical Research towards Clinical Application. Pharmaceutics 2021;13:1782. [PMID: 34834196 DOI: 10.3390/pharmaceutics13111782] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Peng S, Cai J, Bao S. CMBs carrying PTX and CRISPR/Cas9 targeting C‑erbB‑2 plasmids interfere with endometrial cancer cells. Mol Med Rep 2021;24:830. [PMID: 34590151 DOI: 10.3892/mmr.2021.12470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Bansal K, Jha CK, Bhatia D, Shekhar H. Ultrasound-Enabled Therapeutic Delivery and Regenerative Medicine: Physical and Biological Perspectives. ACS Biomater Sci Eng 2021;7:4371-87. [PMID: 34460238 DOI: 10.1021/acsbiomaterials.1c00276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Endo-takahashi Y, Hamano N, Negishi Y. Ultrasound-mediated drug delivery in the combination with micro- and nanobubbles. Official Journal of the Japan Society of Drug Delivery System 2021;36:166-174. [DOI: 10.2745/dds.36.166] [Reference Citation Analysis]
25 Sanwal R, Joshi K, Ditmans M, Tsai SSH, Lee WL. Ultrasound and Microbubbles for Targeted Drug Delivery to the Lung Endothelium in ARDS: Cellular Mechanisms and Therapeutic Opportunities. Biomedicines 2021;9:803. [PMID: 34356867 DOI: 10.3390/biomedicines9070803] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
26 Lin YC, Lin YY, Chen HC, Kuo CY, Liao AH, Chou YL, Hung CL, Shih CP, Wang CH. Ultrasound Microbubbles Enhance the Efficacy of Insulin-Like Growth Factor-1 Therapy for the Treatment of Noise-Induced Hearing Loss. Molecules 2021;26:3626. [PMID: 34199327 DOI: 10.3390/molecules26123626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Zhou L, Wang S, Zhang L, Hu J. Generation and stability of bulk nanobubbles: A review and perspective. Current Opinion in Colloid & Interface Science 2021;53:101439. [DOI: 10.1016/j.cocis.2021.101439] [Cited by in Crossref: 18] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
28 Maestro S, Weber ND, Zabaleta N, Aldabe R, Gonzalez-Aseguinolaza G. Novel vectors and approaches for gene therapy in liver diseases. JHEP Rep 2021;3:100300. [PMID: 34159305 DOI: 10.1016/j.jhepr.2021.100300] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
29 Wang H, Ding L, Xu F, He L, Ye L, Huang L, Zhang L, Luo B. Construction of novel amphiphilic chitosan-polylactide graft copolymer nanodroplets for contrast enhanced ultrasound tumor imaging. J Biomater Appl 2021;:8853282211011766. [PMID: 33899561 DOI: 10.1177/08853282211011766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Fumoto S, Yamamoto T, Okami K, Maemura Y, Terada C, Yamayoshi A, Nishida K. Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs. Pharmaceutics 2021;13:159. [PMID: 33530309 DOI: 10.3390/pharmaceutics13020159] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
31 Kimura S, Harashima H. Current Status and Challenges Associated with CNS-Targeted Gene Delivery across the BBB. Pharmaceutics 2020;12:E1216. [PMID: 33334049 DOI: 10.3390/pharmaceutics12121216] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]